Xing Wang

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 164 citations

Medicine, Gynecology, Oncology +17

Evaluating the air quality impacts of the 2008 Beijing Olympic Games: On-road emission factors and black carbon profiles

Xing Wang, Dane Westerdahl, Lung‐Chi Chen et al. · Atmospheric Environment · 2009 · 146 citations

Natural Sciences, Environmental Engineering, Environmental Sciences +17

Geomorphic contexts and science focus of the Zhurong landing site on Mars

Jianjun Liu, Chunlai Li, Rongqiao Zhang et al. · Nature Astronomy · 2021 · 105 citations · Full text

Natural Sciences, Earth Sciences, Geology +17

Long-lasting farside volcanism in the Apollo basin: Chang'e-6 landing site

Yuqi Qian, J. W. Head, J. R. Michalski et al. · Earth and Planetary Science Letters · 2024 · 80 citations · Full text

Natural Sciences, Astronomy, Earth Sciences +4

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Harpreet Singh, Michael H. Brave, Julia A. Beaver et al. · Clinical Cancer Research · 2016 · 53 citations

Medicine, Oncology, Pharmacology +15